Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1994
Inhibition of activation-induced programmed cell death and restoration of defective immune responses of HIV+ donors by cysteine protease inhibitorsA Sarin, M Clerici, S P Blatt, et al.
Military Medicine|March 1, 1994
A case of Pott's disease in a 20-year-old military dependentM D Grinkemeyer, R C LaBarre, M J Yaszemski, et al.
The American Journal of Medicine|July 1, 1993
Nosocomial Legionnaires' disease: aspiration as a primary mode of disease acquisitionS P Blatt, M D Parkinson, E Pace, et al.
The Journal of Clinical Investigation|February 1, 1994
Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virusM Clerici, T A Wynn, J A Berzofsky, et al.
AIDS (London, England)|April 1, 1995
Rates of p24 antigenemia and viral isolation in comparable white and black HIV-infected subjects. Military Medical Consortium for Applied Retroviral ResearchA E Brown, J R Lane, K F Wagner, et al.
Blood|August 1, 1985
A study of liver biopsies and liver disease among hemophiliacsL M Aledort, P H Levine, M Hilgartner, et al.
Clinical and Diagnostic Laboratory Immunology|July 1, 1995
Presence of neutralizing antibodies to heterologous human immunodeficiency virus type 1 isolates in sera of infected individuals is not predictive of rate of disease progressionR Q Warren, M T Wong, G P Melcher, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 6, 1994
Type 1/type 2 cytokine modulation of T-cell programmed cell death as a model for human immunodeficiency virus pathogenesisM Clerici, A Sarin, R L Coffman, et al.
Journal of Clinical Microbiology|February 1, 1995
Serologic evaluation of human immunodeficiency virus type 1-infected individuals from Argentina and the United States indicates a similar distribution of subgroup B isolatesR Q Warren, M T Wong, G P Melcher, et al.
The Journal of Infectious Diseases|December 1, 1993
Longitudinal analysis of the humoral immune response to human immunodeficiency virus type 1 (HIV-1) gp160 epitopes in rapidly progressing and nonprogressing HIV-1-infected subjectsM T Wong, R Q Warren, S A Anderson, et al.
Pageof 3